Scientific Reports And Studies Behind Turboforte
We are an internationally approved and recognised medical device that is proud to show our certifications.
Registered by the Australian Governments Therapeutic Goods Association (TGA).
Turboforte is approved for use by the US Food and Drug Administration
Turboforte meets the European Union's (EU) standards for health, safety, and environmental protection.
Medical
Using the latest in medical innovation, we’ve created an answer for clearer, healthier and stronger lungs – all in one small but powerful package.
26+ million
ASTHMA
8.3% of Americans have asthma. Of these 26.5 million, 20.4 million are adults and 6.1 million are children. Patients with asthma reported 11 million visits to a doctor’s office and 1.7 million visits to hospital outpatient departments.
8.9+ million
BRONCHITIS
Bronchitis is inflammation of the bronchi, the air pathways to the lungs. In 2016, more than 8.9 million Americans were diagnosed with chronic bronchitis and nearly 75 percent of these cases involved people over the age of 45.
29+ million
COPD
Chronic obstructive pulmonary disease is a group of group of progressive lung diseases. The most common are emphysema and chronic bronchitis. There’s no cure for COPD, but treatment can help ease symptoms, lower the chance of complications. and generally improve quality of life.
Clinical Trials
Turboforte Lung Physio and other similar flutter valve devices have participated in many clinical trials, and have also undertaken rigorous testing in many hospitals and universities world-wide. Below is a representation of a few of the completed studies.
Oscillatory Positive Expiratory Pressure in Chronic Obstructive Pulmonary Disease
Read More...
Study Oscillatory Positive Expiratory Pressure in Chronic Obstructive Pulmonary Disease Finding “In COPD patients with chronic sputum production, PEQ and SGRQ scores, FVC and 6MWD
Noncystic Fibrosis Bronchiectasis
Read More...
Study Noncystic Fibrosis Bronchiectasis: Regional Abnormalities and Response to Airway Clearance Therapy Using Pulmonary Functional Magnetic Resonance Imaging Finding “There was CT and MRI evidence
Study: OPEP in lower respiratory tract infections
Read More...
Study OPEP in lower respiratory tract infections Finding “In conclusion, OPEP exhibited a greater effectiveness in draining sputum, improving oxygenation and reducing inflammatory status in
Functional Respiratory Imaging Approach to Oscillating Positive Expiratory Pressure Device
Read More...
Study A Functional Respiratory Imaging Approach to the Effect of an Oscillating Positive Expiratory Pressure Device in Chronic Obstructive Pulmonary Disease Finding “ The utilization
Oscillating Positive Expiratory Pressure on Respiratory Resistance
Read More...
Study Oscillating Positive Expiratory Pressure on Respiratory Resistance in Chronic Obstructive Pulmonary Disease With a Small Amount of Secretion: A Randomized Clinical Trial Finding “The
Effects of an Airway Clearance Device on Inflammation
Read More...
Study Effects of an Airway Clearance Device on Inflammation, Bacteriology, and Mucus Transport in Bronchiectasis Finding “The use of a flutter valve for 30 min/d